1 / 66

Critical Thinking in Medicine

Critical Thinking in Medicine. Eric S. Farbman, MD. Scams. Hoaxes. Parkinson’s Disease: Bogus Treatments. Eric S. Farbman, MD. Quackery. Hoaxes, Scams, Quackery. Non-medical treatments without proven benefit Medical fraud

turi
Download Presentation

Critical Thinking in Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Critical Thinking in Medicine Eric S. Farbman, MD

  2. Scams Hoaxes Parkinson’s Disease:Bogus Treatments Eric S. Farbman, MD Quackery

  3. Hoaxes, Scams, Quackery • Non-medical treatments without proven benefit • Medical fraud • Designed to enrich the promoter of the treatment more so than the patient • In some cases, these can be dangerous to the health of the patient as well

  4. Why Are People Vulnerable? • Lack of suspicion—if it is on television, the internet, etc., then it must be true • Overconfidence—some people believe that they are better equipped than scientists in determining whether something works • Desperation—the sincere hope that something works when nothing else has • Conspiracy—distrustful of the medical profession but attracted to “natural” methods

  5. Why Do the Methods Seem to Work? • There is a poor grasp of innate probability • In a group of 23 people, what are the odds that two share the same birthday? • There is a belief that all effects must have deliberate causes • There is a tendency towards selective memory • There is the placebo effect • There is a desire to please the individual • There is the natural course of the disease

  6. What is Quackery? • It is the promotion of methods that have no evidence and lack a scientific rationale • Malpractice usually involves negligence rather than fraud • Some promoters are scam artists, some are blind “true believers”

  7. Types of Hoax Treatments • Vitamins/Supplements • Procedures • “Alternative medicine” practitioners

  8. Supplements

  9. Getting a Medication Approved • Since 1938, every medication has to go through a New Drug Application (NDA) process before getting approval in the U.S. • The goals of the NDA are: • Is the drug safe and effective for its proposed use, and do the benefits outweigh the risks? • Is the labelling (package insert) appropriate, and what should it contain? • Are the manufacturing methods adequate to maintain the drug’s identity, strength, and purity?

  10. Studies Required by the FDA • First the sponsor must submit data showing that the drug is reasonably safe for use in small-scale clinical studies • At this pre-clinical stage, the FDA will ask for: • A pharmacological profile of the drug • Determine acute toxicity in at least two species of animals • Conduct short-term toxicity studies ranging from two weeks to three months

  11. Studies Required by the FDA:On the Road to Drug Approval • Phase I: Develop drug’s safety profile • Normally subjects are healthy volunteers • Determines how drug is absorbed, distributed in the body, metabolized, and excreted • Phase II: Determine the drug’s safety and assess side effects • Given to volunteers who have the disease • Determine optimal dosage of the drug

  12. Studies Required by the FDA:On the Road to Drug Approval • Phase III: Verify the effectiveness of the drug against the condition that it targets • This also continues to investigate the safety of the drug and record possible side effects and adverse reactions from long-term use. • These studies are randomized, double-blind, placebo-controlled studies. • Often have at least 1000 patients enrolled • If the medication is effective, the trial is deemed successful—“pivotal”. Normally two pivotal trials are needed to ensure validity of the trials

  13. Studies Required by the FDA:After Drug Approval • Phase IV: Once the drug is on the market, the company must continue to perform observational studies to evaluate the drug’s safety during routine use. • The company may also monitor any usage of the drug for un-approved indications. • Trials may be done based on those usages, but the company CANNOT advertise “off-label” use

  14. Studies Required forSupplement Approval None!

  15. Health and Education Act of 1994 • Defined a dietary supplement as: • A product (other than tobacco) that is intended to supplement the diet • Is intended for ingestion in pill, capsule, tablet, or liquid form • Is not represented for use as a conventional food • Is labelled as a “dietary supplement” • Nutritional support statements do not have to be approved by the FDA • This law has made it very difficult for the FDA to ban dangerous dietary supplements.

  16. “Legitimate” Supplements • Vitamin E • Gluathione • Coenzyme Q10 • Vitamin B6 • Folic Acid Which of these agents has a double-blind trial that supports its benefit in PD?

  17. CoEnzyme Q10

  18. CoEnzyme Q10 • Eighty people in study • Randomized to placebo, 300mg/day, 300mg twice/day, 300mg 4x/day • Followed for 16 months or until the patient needed treatment with levodopa • Primary variable was a change in UPDRS • Statistically signifcant benefits seen at highest dose, trending towards benefit at lower doses

  19. Why Is CoQ10 Thought to Work? • Causes of Parkinson’s Disease are not known • Thought to be at least partially due to oxidation (“rusting”) of the brain • CoQ10 is a potent anti-oxidant • So, what about other anti-oxidants?

  20. Vitamin E • One of the few supplements to have a well-designed negative trial • Original selegiline trials had four arms • Selegiline/Placebo • Selegiline/Vitamin E • Placebo/Vitamin E • Placebo/Placebo • No effect on progression of PD by itself • No enhancement of selegiline in combination

  21. Glutathione • 9 patients with early, untreated PD were given IV gluathione 600mg twice/day for 30 days • All improved significantly after therapy as measured by CURS • Evaluates rigidity, tremor, speech, facial expression, bradykinesia, gait, postural stability • After 30 days of therapy were completed, the therapeutic effect lasted an additional 2 months

  22. 100 Ropinirole (n=464) * 80 Placebo (n=464) ‡ 73% † 60 60% 57% Percentage of Patients 53% 40 41% 40% 20 n=187 n=193 n=146 n=137 n=131 n=134 0 n=187 n=193 n=146 n=137 n=131 n=134 TREAT RLS US1 TREAT RLS 12 TREAT RLS 23 Problems with Gluathione Study • Very small sample size • No control group—no placebo arm • Original study done in 1996; where are the follow-up studies?

  23. Less Reputable Supplements

  24. Other Treatments • Prakotin • I’m not sure what it is • It shows up on some websites • The word “prakotin” does not show up in the medline database

  25. Low Dose Naltrexone • Naltrexone was approved by the FDA in 1984 • Dose was 50mg for the purpose of helping heroin or opium addicts • Works by blocking opioid receptors • Supposedly a smaller dose (4.5mg) enhances the body’s immune system and its response to many diseases including Parkinson’s disease

  26. Low Dose Naltrexone (cont’d) • There is nothing in the literature to support its use in neurological disease • There is virtually nothing in the literature to support its use in anything • Any benefits reported for Parkinson disease are purely anecdotal

  27. LDN in the Medical Literature

  28. “Medical” Procedures

  29. Chelation • A chelator is an organic compound that forms stable bonds with metal atoms. • They often are used for acute metal toxicity • Often times they have serious side effects

  30. Chelating Agents • Dimercaprol • Given intramuscularly • Used for arsenic, lead, mercury, cadmium poisoning • Side effects: Headache, nausea, vomiting • Penicillamine • Treatment for copper poisoning and Wilson’s disease • Side effects: Aplastic anemia, lupus, hemolytic anemia

  31. Chelating Agents (cont’d) • Edetate (EDTA) • Possible chelator of many things • Usually used for lead poisoning • Side effect: nephrotoxicity • Deferoxamine • Used for acute iron intoxication • Does not cross blood brain barrier • Side effects: skin reactions, neurotoxicity (i.e. retinal degeneration), hepatic and renal dysfunction, severe coagulopathies, hypotensive shock

  32. Chelation Therapy • There are no trials that show any benefit in PD • Even if we assume that excess iron is part of the pathology, there is no chelator that can effectively cross into the brain to remove this iron without side effects • There are well-designed trials for other conditions which have yielded negative results • Using chelation instead of proven treatments (i.e. CABG) can have fatal consequences

  33. Hyperbaric Medicine • The delivery of pressurized oxygen to the body • Useful (and approved) for treating • Decompression sickness (“The Bends”) • Carbon Monoxide Poisoning • Cyanide poisoning • Burns • Necrotizing soft tissue infections

  34. Hyperbaric Medicine in PD • 2 abstracts/articles from various International Congresses on Hyperbaric Medicine • One article (originally in Russian literature) • All supposedly show benefit

  35. Hyperbaric in PD: Abstract 1 • 72 y.o. male diagnosed with idiopathic PD • Started on sinemet 10/100 three times/day • Eighteen months after diagnosis, he started on hyperbaric oxygenation and had great results. He was also able to come off of his sinemet • Problems: • Dose of sinemet is insufficient • Disease is probably mild at time of treatment • Scale used to rate improvement is not validated

  36. Hyperbaric in PD: Abstract 2 • Fifteen patients (8 men, 7 women) • Etiology of PD: • 7 idiopathic • 4 vasculopathic • 3 post-encephalic • 1 other kind • No controls • Nothing said about medication changes • Difficult to know what to make of results

  37. Hyperbaric in PD: Russian article • 64 patients (29 men, 35 women) • Duration of illness ranged from 1 – 15 years • Etiology • Atherosclerosis of cerebral vessels in 49 patients • This combined with arterial hypertension in 6 • History of encephalitis in 8 • Closed head trauma in 1 • Results: • “Good treatment results were noted in 18…” • “Therapeutic effect was considered satisfactory in 26…” • No measurement scales of any kind were used!

  38. Other Devices with No FDA Approved Indications

  39. “Alternative Medicine” Practitioners

More Related